Pharmacokinetics and pharmacodynamics of inhaled corticosteroids

被引:168
作者
Derendorf, H [1 ]
Hochhaus, G
Meibohm, B
Möllmann, H
Barth, J
机构
[1] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
[2] Ruhr Univ Bochum, D-4630 Bochum, Germany
关键词
inhaled corticosteroids; pharmacokinetics; pharmacodynamics; safety; mathematical modeling;
D O I
10.1016/S0091-6749(98)70156-3
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
There are significant differences in the pharmacokinetic properties of inhaled corticosteroids currently used in medical practice. All are rapidly cleared from the body but they show varying levels of oral bioavailability and more importantly variation in the rate of absorption after inhalation. Oral bioavailability is lowest for fluticasone propionate, indicating a low potential for unwanted systemic corticosteroid effects. Mathematical modeling has shown pulmonary residence times to be longest for fluticasone propionate and triamcinolone acetonide but shortest for budesonide and flunisolide. These properties appear to relate to pulmonary solubility, which appears to be the rate-limiting step in the absorption process.
引用
收藏
页码:S440 / S446
页数:7
相关论文
共 23 条
[1]   BUDESONIDE - AN UPDATED REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC EFFICACY IN ASTHMA AND RHINITIS [J].
BROGDEN, RN ;
MCTAVISH, D .
DRUGS, 1992, 44 (03) :375-407
[2]   FLUNISOLIDE METABOLISM AND DYNAMICS OF A METABOLITE [J].
CHAPLIN, MD ;
ROOKS, W ;
SWENSON, EW ;
COOPER, WC ;
NERENBERG, C ;
CHU, NI .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) :402-413
[3]   CORRELATION OF FLUNISOLIDE PLASMA-LEVELS TO EOSINOPENIC RESPONSE IN HUMANS [J].
CHAPLIN, MD ;
COOPER, WC ;
SEGRE, EJ ;
OREN, J ;
JONES, RE ;
NERENBERG, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1980, 65 (06) :445-453
[4]   PHARMACOKINETICS OF TRIAMCINOLONE ACETONIDE AFTER INTRAVENOUS, ORAL, AND INHALED ADMINISTRATION [J].
DERENDORF, H ;
HOCHHAUS, G ;
ROHATAGI, S ;
MOLLMANN, H ;
BARTH, J ;
SOURGENS, H ;
ERDMANN, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (03) :302-305
[5]  
Faicoz C, 1995, J CLIN PHARMACOL, V35, P927
[6]  
Falcoz C., 1996, European Respiratory Journal Supplement, V9, p162S
[7]  
Falcoz C., 1996, British Journal of Clinical Pharmacology, V41, p459P
[8]   Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model [J].
Hochhaus, G ;
Mollmann, H ;
Derendorf, H ;
GonzalezRothi, RJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (10) :881-892
[9]  
Jenner WN, 1988, BIOANALYSIS DRUGS ME, P77
[10]   Pharmacokinetics of intravenous fluticasone propionate in healthy subjects [J].
Mackie, AE ;
Ventresca, GP ;
Fuller, RW ;
Bye, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (06) :539-542